A Study to Evaluate Non-significant Risk Operation Magnetic Resonance Imaging for MRI Guided Ablation
- Conditions
- Healthy
- Interventions
- Device: Magnetic Resonance Imaging (MRI)
- Registration Number
- NCT04880226
- Lead Sponsor
- Mayo Clinic
- Brief Summary
The result of these studies will be used to improve patient care through assessment of new technology to determine whether it is beneficial (i.e. improving data acquisition speed or image quality) during iMRI procedures.
- Detailed Description
This proposal includes evaluation of advanced MR imaging methods in the iMRI environment and will operate within the NSR guidelines for data acquisition established by the FDA/CDRH. The significant testing by vendor and Mayo staff prior to in vivo use, assure the safety of these studies and overall system stability.
The result of these studies will be used to improve patient care through assessment of new technology to determine whether it is beneficial (i.e. improving data acquisition speed or image quality) during iMRI procedures.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 100
- Male or female.
- Age ≥ 18 years.
- Healthy volunteers or patients already scheduled for a MR-guided procedure.
- Individuals 18 years of age.
- Pregnant women.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Patients receiving MRI-guided procedures Magnetic Resonance Imaging (MRI) As described in the study protocol this imaging would be performed to evaluate a given sequence for potential benefit during MR-guided interventions. Healthy Volunteers Magnetic Resonance Imaging (MRI) Imaging of healthy volunteers would performed to optimize image parameters (contrast, SNR) prior to clinical imaging of actual patients receiving treatment.
- Primary Outcome Measures
Name Time Method Clinical determination whether the sequence improves patient care during MRI-guided procedures. 3 years It will be determined whether the sequence under investigation improves one of the following: 1. lesion targeting (e.g. better guidance of applicators by reduction of metal artifact), 2. lesion ablation (e.g. improved MR thermometry, visualization of cryoablation ice), or 3. accurate assessment of treatment outcome (e.g. margins of ablation relative to lesion boundaries.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Mayo Clinic in Rochester
🇺🇸Rochester, Minnesota, United States